• Publications
  • Influence
Acute graft-vs-host disease: pathobiology and management.
Acute graft-vs-host disease (GVHD) is a major obstacle to safe allogeneic hematopoietic stem cell transplantation (HSCT), leading to a significant morbidity and mortality. GVHD occurs whenExpand
  • 310
  • 25
Risk factors for acute GVHD and survival after hematopoietic cell transplantation.
Risk factors for acute GVHD (AGVHD), overall survival, and transplant-related mortality were evaluated in adults receiving allogeneic hematopoietic cell transplants (1999-2005) from HLA-identicalExpand
  • 376
  • 17
Inhibition of aldehyde dehydrogenase and retinoid signaling induces the expansion of human hematopoietic stem cells.
Aldehyde dehydrogenase (ALDH) is an enzyme that is expressed in the liver and is required for the conversion of retinol (vitamin A) to retinoic acids. ALDH is also highly enriched in hematopoieticExpand
  • 416
  • 17
  • PDF
Pathophysiologic mechanisms of acute graft-vs.-host disease.
Graft-vs.-host disease (GVHD) remains the major toxicity of allogeneic bone marrow transplantation. Mechanistic studies in experimental animal models provide a better understanding of the complexExpand
  • 333
  • 16
Endothelial progenitor cell infusion induces hematopoietic stem cell reconstitution in vivo.
Hematopoietic stem cells (HSCs) reside in association with bone marrow (BM) sinusoidal vessels in vivo, but the function of BM endothelial cells (ECs) in regulating hematopoiesis is unclear. WeExpand
  • 108
  • 11
A molecular basis for MHC class II--associated autoimmunity.
Class II major histocompatibility (MHC) molecules have an immunoregulatory role. These cell-surface glycoproteins present fragments of protein antigens (or peptides) to thymus-derived lymphocytes (TExpand
  • 656
  • 10
Gene Expression Signatures That Predict Radiation Exposure in Mice and Humans
Background The capacity to assess environmental inputs to biological phenotypes is limited by methods that can accurately and quantitatively measure these contributions. One such example can be seenExpand
  • 156
  • 9
  • PDF
Granulocyte colony-stimulating factor "mobilized" peripheral blood progenitor cells accelerate granulocyte and platelet recovery after high-dose chemotherapy.
Hematopoietic growth factors have been used to accelerate engraftment after bone marrow transplantation and to "mobilize" peripheral blood progenitor cells (PBPC). We report on the data in 85Expand
  • 285
  • 8
  • PDF
Pleiotrophin regulates the expansion and regeneration of hematopoietic stem cells
Hematopoietic stem cell (HSC) self-renewal is regulated by both intrinsic and extrinsic signals. Although some of the pathways that regulate HSC self-renewal have been uncovered, it remains largelyExpand
  • 240
  • 8
  • PDF
Umbilical cord blood expansion with nicotinamide provides long-term multilineage engraftment.
BACKGROUND Delayed hematopoietic recovery is a major drawback of umbilical cord blood (UCB) transplantation. Transplantation of ex vivo-expanded UCB shortens time to hematopoietic recovery, butExpand
  • 167
  • 7
  • PDF